Acute hippocampal slices have been used for more than two decades to study the effect of anoxia, oxygen and glucose deprivation, and excitotoxic amino acids (
Fountain and Teyler 1987;
Schurr and Rigor 1989;
Schurr et al. 1995;
Schurr et al. 1995;
Zhang and Lipton 1999;
Ferchmin et al. 2000;
Ferchmin et al. 2005). In acute slices, most of the circuitry of the original tissue is preserved; the ratio of interneurons to pyramidal neurons is unchanged relative to in vivo models. Stimulation of afferents allows measurement of synaptically elicited population spikes (PSs) from about 30 to 60 pyramidal neurons. The size of the PS is directly proportional to the number of functionally active pyramidal neurons (
Andersen et al. 1971), thus, quantification of PSs provides a measure of the extent of neuronal damage. This preparation is well suited to the study of early functional neuronal damage before the onset of cell death. Collectively, these observations strongly support acute hippocampal slices as a an excellent model system for studying early synaptic excitotoxic and neuroprotective events of OP neurotoxicity. It might be more important to understand these early changes when intervention is still possible rather than studying neuronal death when intervention is not useful any more. Furthermore, comparisons of early effects of experimental ischemia on electric activity in acute slices versus delayed neuronal cell death in cultured slices is consistent with the concept that the loss of electrophysiological activity in acute slices and neuronal cell death slice cultures represent the same event in a different time scale (
Small et al. 1997). This is supported by the work of Schurr and colleagues (
Schurr and Rigor 1995) showing that drugs that protect against the loss of PSs in acute slices also protect against excitotoxicity in neuronal cell culture, organotypic slices or
in vivo models.
Under the experimental conditions employed in our studies, the waveforms recorded before and after POX, application did not show any consistent alterations other than a decrease of the PS area (). No seizures were observed during or after POX superfusion as discussed in (
Harrison et al. 2004). POX decreased the PSs area in a time- and dose-dependent manner; however, there was a fraction of the PSs that was resistant despite increased exposure time or concentration. POX concentrations higher than 100 µM () or exposures longer than 10 min () did not increase POX inhibition of PSs.
AChE inhibition accounts for more than 90% of the neurotoxic effect of OPs
in vivo and only 10% could be explained by other mechanisms (
Maxwell et al. 2006). In acute slices continuously superfused with ACSF, the effects of AChE inhibition appear to be less prominent because ACh cannot accumulate as
in vivo. The role of AChE in POX neurotoxicity in acute slices is discussed below. In addition to inhibiting AChE, OPs induce neuronal excitotoxicity and apoptosis (
Carlson et al. 2000;
Li et al. 2010), thus silencing a fraction of neurons and decreasing the area of the PS. Since 4R protects slices against NMDA excitotoxicity by a nicotinic anti-apoptotic mechanism (
Ferchmin et al. 2005;
Ferchmin et al. 2009) we tested here its effect against POX.
The neuroprotective effect of 4R applied 30 min after POX was dose dependent with an ED50 of 0.8 µM (). 4R applied before POX was marginally more efficacious than when applied 30 min after POX (). 4R protects with similar efficacy when applied before or after POX exposure () suggesting that it does not act as an antidote but rather by activation of a cell survival signaling
pathway.
Atropine, a muscarinic antagonist, is a life saving antidote for patients poisoned with OPs because it inhibits the muscarinic overstimulation cause by AChE inhibition. However, in slices atropine was not efficacious. shows that 1 or 50 µM atropine in the absence of POX did not affect the PS area. When applied prior to application of POX, 1 µM atropine did not significantly prevent the decrease of PSs by POX. The toxic effect of POX was not ameliorated by 1, 5 or 50 µM atropine applied 30 min after POX. Interestingly, 1 µM atropine seems to act synergistically with 10 µM 4R to protect against POX neurotoxicity when applied 30 min after POX (). The protection of PSs by 4R plus atropine was 100% when added 30 min after POX exposure, and still highly significant when added 1 hour after POX exposure. It is not possible to rule out the possibility that atropine acts in part by a nicotinic mechanism (
Zwart and Vijverberg 1997,
1998).
Pralidoxime is another classic antidote used clinically on victims of OPs poisoning because of its ability to regenerate AChE activity (
Petroianu et al. 2007). Interestingly, pralidoxime promoted the recovery of the PSs from POX poisoning albeit with an efficacy approximately 10 fold lower than 4R (). The neuroprotective effects of pralidoxime on PSs were coincident with significant protection of AChE activity, suggesting a functional link between AChE activity and PS size. However, in contrast to pralidoxime, 4R did not reactivate AChE () but yet protected the PSs. These data suggest there is no causal relationship between AChE activity and preservation of PSs. Further support for this conclusion are the findings that: 1) During dissection, slicing and incubation for 1 hour in the recording chamber, 90% of the AChE activity is lost () while the electrophysiological activity remains stable for hours. 2) the discrepancy between the concentration-effect relationships for POX inhibition of AChE and POX effects on PSs. With respect to the latter, 10 nM and 10 µM POX inhibited 82% and 88% of AChE activity () but 100 µM POX was needed to reach the plateau of PS inhibition (). This conclusion, however, must be made with caution because the interaction of POX with different esterases is dynamic and complex (
Estevez et al. 2011) and it is conceivable that a small pool of an esterase reactivated by pralidoxime reactivates the electrophysiological activity of slices. The lack of involvement of AChE is further supported by the finding that during dissection, slicing and incubation for 1 hour in the recording chamber 90% of the AChE activity is lost () while the electrophysiological activity remains stable for hours with only minor deviations from in vivo models. Although we do not know the exact mechanism of AChE loss of activity in slices, there are reports, which suggest possible mechanisms. In the mammalian brain, AChE is present in various forms and in different compartments. Most of AChE is anchored in cell membranes by a transmembrane protein PRiMA (proline-rich membrane anchor) (
Perrier et al. 2002;
Xie et al. 2010). Not only PRiMA anchored AChE can detach but there are soluble forms that are amenable to be released. In addition, active secretion of AChE from neurons and PC12 cells was described (
Llinas and Greenfield 1987;
Schweitzer 1993).
Collectively, these data suggest that AChE inhibition is not a predominant mechanism of POX neurotoxicity in acute hippocampal slices probably because there is not a significant accumulation of ACh. Therefore, the acute slice preparation seems to be a uniquely suited model to study early events of OP neurotoxicity in the absence of a massive accumulation of ACh.
In conclusion, 4R protected the function of CA1 neurons against the neurotoxic effects of POX. Although the mechanism of neuroprotection in this model system was not elucidated, we hypothesize that 4R protects against POX by a mechanism similar to the one involved in protection against NMDA excitotoxicity (
Ferchmin et al. 2005).